Adelphi Research UK
Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide both UK and Multi Local clients towards better business decisions. We bring insights to life through visually impactful storytelling and workshops and inspire brand teams to take action.
Established since 2000, we have extensive expertise in pharma, and also span OTC and consumer healthcare applying both qualitative and quantitative methods. Our Multi Local approach provides a network of expert local offices and partners across the globe, offering a unique bottom-up solution.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Avalere Health
Avalere Health is a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Working from advisory to performance, we combine our knowledge and expertise across our disciplines…
Cuttsy + Cuttsy
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and supporting understanding and outcomes across trials, treatments and beyond.
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Fox&Cat
Fox&cat is an award-winning healthcare communications agency which creates inspirational campaigns and programmes that exceed expectations. Priding itself on delivering outstanding outcomes with meaningful impact, fox&cat is a vehemently purpose-driven…
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Genetic Digital
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Healthcare Research Worldwide
We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
Inizio
Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.
Page & Page Health
Page & Page is an independent creative agency on a mission to close the healthcare gap through the power of imaginative communication.
Red Thread Market Access Ltd
Blending brilliant writing with in-depth market access and reimbursement expertise
- 1
- 2
Company Details
Latest Content from PMHub
Knowing your audience is key to successful medical education
Press Releases | September 7, 2016 | Lucid Group Communications Limited
Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...
How to enable each healthcare professional to fully understand your product
White Papers and Resources | September 7, 2016 | Anthill Agency
Read these three articles to understand how working at an individual level benefits all customers:
Alzheimer’s disease: reviewing the immediate treatment horizon
White Papers and Resources | September 1, 2016 | Blue Latitude Health
Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.
A stumble, but not a fall – what’s next for Opdivo?
White Papers and Resources | August 25, 2016 | Blue Latitude Health
Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.
Meet Anthill at conferences in London
White Papers and Resources | August 19, 2016 | Anthill Agency
October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit
Immuno-oncology; bringing patients closer to treatment
White Papers and Resources | August 18, 2016 | Blue Latitude Health
What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?
Therapy Watch market snapshots
White Papers and Resources | August 12, 2016 | Inizio
Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...
Case Study: Private market opportunity for a travel vaccine
White Papers and Resources | August 12, 2016 | Inizio
Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...
Infographic: Conference Live
White Papers and Resources | August 12, 2016 | Inizio
Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...
Blog: The Cost of Counterfeits
White Papers and Resources | August 12, 2016 | Inizio
The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.